Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac Differentiation

Abstract

Fetal maternal stem cell transfer appears to be a critical mechanism in the maternal response to cardiac injury. Furthermore, we have identified Cdx2 cells as a novel cell type for potential use in cardiovascular regenerative therapy.